The IL-17 receptor IL-17RE mediates polyIC-induced exacerbation of experimental allergic asthma

Abstract Background The interleukin 17 receptor E (IL-17RE) is specific for the epithelial cytokine interleukin-17C (IL-17C). Asthma exacerbations are frequently caused by viral infections. Polyinosinic:polycytidylic acid (pIC) mimics viral infections through binding to pattern recognition receptors...

Full description

Bibliographic Details
Main Authors: Giovanna Vella, Lars Lunding, Felix Ritzmann, Anja Honecker, Christian Herr, Michael Wegmann, Robert Bals, Christoph Beisswenger
Format: Article
Language:English
Published: BMC 2020-07-01
Series:Respiratory Research
Online Access:http://link.springer.com/article/10.1186/s12931-020-01434-9
id doaj-8948d86f68eb4d17be64de5092417485
record_format Article
spelling doaj-8948d86f68eb4d17be64de50924174852020-11-25T03:46:33ZengBMCRespiratory Research1465-993X2020-07-012111810.1186/s12931-020-01434-9The IL-17 receptor IL-17RE mediates polyIC-induced exacerbation of experimental allergic asthmaGiovanna Vella0Lars Lunding1Felix Ritzmann2Anja Honecker3Christian Herr4Michael Wegmann5Robert Bals6Christoph Beisswenger7Department of Internal Medicine V – Pulmonology, Allergology and Critical Care Medicine, Saarland UniversityDivision of Asthma Exacerbation & Regulation, Priority Area Asthma and Allergy, Leibniz Lung Center Borstel, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL)Department of Internal Medicine V – Pulmonology, Allergology and Critical Care Medicine, Saarland UniversityDepartment of Internal Medicine V – Pulmonology, Allergology and Critical Care Medicine, Saarland UniversityDepartment of Internal Medicine V – Pulmonology, Allergology and Critical Care Medicine, Saarland UniversityDivision of Asthma Exacerbation & Regulation, Priority Area Asthma and Allergy, Leibniz Lung Center Borstel, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL)Department of Internal Medicine V – Pulmonology, Allergology and Critical Care Medicine, Saarland UniversityDepartment of Internal Medicine V – Pulmonology, Allergology and Critical Care Medicine, Saarland UniversityAbstract Background The interleukin 17 receptor E (IL-17RE) is specific for the epithelial cytokine interleukin-17C (IL-17C). Asthma exacerbations are frequently caused by viral infections. Polyinosinic:polycytidylic acid (pIC) mimics viral infections through binding to pattern recognition receptors (e.g. TLR-3). We and others have shown that pIC induces the expression of IL-17C in airway epithelial cells. Using different mouse models, we aimed to investigate the function of IL-17RE in the development of experimental allergic asthma and acute exacerbation thereof. Methods Wild-type (WT) and IL-17RE deficient (Il-17re −/− ) mice were sensitized and challenged with OVA to induce allergic airway inflammation. pIC or PBS were applied intranasally when allergic airway inflammation had been established. Pulmonary expression of inflammatory mediators, numbers of inflammatory cells, and airway hyperresponsiveness (AHR) were analyzed. Results Ablation of IL-17RE did not affect the development of OVA-induced allergic airway inflammation and AHR. pIC induced inflammation independent of IL-17RE in the absence of allergic airway inflammation. Treatment of mice with pIC exacerbated pulmonary inflammation in sensitized and OVA-challenged mice in an IL-17RE-dependent manner. The pIC-induced expression of cytokines (e.g. keratinocyte-derived chemokine (KC), granulocyte-colony stimulating factor (G-CSF)) and recruitment of neutrophils were decreased in Il-17re −/− mice. pIC-exacerbated AHR was partially decreased in Il-17re −/− mice. Conclusions Our results indicate that IL-17RE mediates virus-triggered exacerbations but does not have a function in the development of allergic lung disease.http://link.springer.com/article/10.1186/s12931-020-01434-9
collection DOAJ
language English
format Article
sources DOAJ
author Giovanna Vella
Lars Lunding
Felix Ritzmann
Anja Honecker
Christian Herr
Michael Wegmann
Robert Bals
Christoph Beisswenger
spellingShingle Giovanna Vella
Lars Lunding
Felix Ritzmann
Anja Honecker
Christian Herr
Michael Wegmann
Robert Bals
Christoph Beisswenger
The IL-17 receptor IL-17RE mediates polyIC-induced exacerbation of experimental allergic asthma
Respiratory Research
author_facet Giovanna Vella
Lars Lunding
Felix Ritzmann
Anja Honecker
Christian Herr
Michael Wegmann
Robert Bals
Christoph Beisswenger
author_sort Giovanna Vella
title The IL-17 receptor IL-17RE mediates polyIC-induced exacerbation of experimental allergic asthma
title_short The IL-17 receptor IL-17RE mediates polyIC-induced exacerbation of experimental allergic asthma
title_full The IL-17 receptor IL-17RE mediates polyIC-induced exacerbation of experimental allergic asthma
title_fullStr The IL-17 receptor IL-17RE mediates polyIC-induced exacerbation of experimental allergic asthma
title_full_unstemmed The IL-17 receptor IL-17RE mediates polyIC-induced exacerbation of experimental allergic asthma
title_sort il-17 receptor il-17re mediates polyic-induced exacerbation of experimental allergic asthma
publisher BMC
series Respiratory Research
issn 1465-993X
publishDate 2020-07-01
description Abstract Background The interleukin 17 receptor E (IL-17RE) is specific for the epithelial cytokine interleukin-17C (IL-17C). Asthma exacerbations are frequently caused by viral infections. Polyinosinic:polycytidylic acid (pIC) mimics viral infections through binding to pattern recognition receptors (e.g. TLR-3). We and others have shown that pIC induces the expression of IL-17C in airway epithelial cells. Using different mouse models, we aimed to investigate the function of IL-17RE in the development of experimental allergic asthma and acute exacerbation thereof. Methods Wild-type (WT) and IL-17RE deficient (Il-17re −/− ) mice were sensitized and challenged with OVA to induce allergic airway inflammation. pIC or PBS were applied intranasally when allergic airway inflammation had been established. Pulmonary expression of inflammatory mediators, numbers of inflammatory cells, and airway hyperresponsiveness (AHR) were analyzed. Results Ablation of IL-17RE did not affect the development of OVA-induced allergic airway inflammation and AHR. pIC induced inflammation independent of IL-17RE in the absence of allergic airway inflammation. Treatment of mice with pIC exacerbated pulmonary inflammation in sensitized and OVA-challenged mice in an IL-17RE-dependent manner. The pIC-induced expression of cytokines (e.g. keratinocyte-derived chemokine (KC), granulocyte-colony stimulating factor (G-CSF)) and recruitment of neutrophils were decreased in Il-17re −/− mice. pIC-exacerbated AHR was partially decreased in Il-17re −/− mice. Conclusions Our results indicate that IL-17RE mediates virus-triggered exacerbations but does not have a function in the development of allergic lung disease.
url http://link.springer.com/article/10.1186/s12931-020-01434-9
work_keys_str_mv AT giovannavella theil17receptoril17remediatespolyicinducedexacerbationofexperimentalallergicasthma
AT larslunding theil17receptoril17remediatespolyicinducedexacerbationofexperimentalallergicasthma
AT felixritzmann theil17receptoril17remediatespolyicinducedexacerbationofexperimentalallergicasthma
AT anjahonecker theil17receptoril17remediatespolyicinducedexacerbationofexperimentalallergicasthma
AT christianherr theil17receptoril17remediatespolyicinducedexacerbationofexperimentalallergicasthma
AT michaelwegmann theil17receptoril17remediatespolyicinducedexacerbationofexperimentalallergicasthma
AT robertbals theil17receptoril17remediatespolyicinducedexacerbationofexperimentalallergicasthma
AT christophbeisswenger theil17receptoril17remediatespolyicinducedexacerbationofexperimentalallergicasthma
AT giovannavella il17receptoril17remediatespolyicinducedexacerbationofexperimentalallergicasthma
AT larslunding il17receptoril17remediatespolyicinducedexacerbationofexperimentalallergicasthma
AT felixritzmann il17receptoril17remediatespolyicinducedexacerbationofexperimentalallergicasthma
AT anjahonecker il17receptoril17remediatespolyicinducedexacerbationofexperimentalallergicasthma
AT christianherr il17receptoril17remediatespolyicinducedexacerbationofexperimentalallergicasthma
AT michaelwegmann il17receptoril17remediatespolyicinducedexacerbationofexperimentalallergicasthma
AT robertbals il17receptoril17remediatespolyicinducedexacerbationofexperimentalallergicasthma
AT christophbeisswenger il17receptoril17remediatespolyicinducedexacerbationofexperimentalallergicasthma
_version_ 1724505627406893056